ISPOR - Role of Patient-Reported Outcome Evaluation in the Approval of Orphan Drugs- A Review of 15 Year Approvals by the FDA and the EMA

Full Text

Role of Patient-Reported Outcome Evaluation in the Approval of Orphan Drugs- A Review of 15 Year Approvals by the FDA and the EMA

Abstract

Authors

B Arnould C Acquadro S Lanar I Savre

Back to Volume 21, Supplemental S1

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now